GDC 0134

Drug Profile

GDC 0134

Alternative Names: GDC-0134; RG6000

Latest Information Update: 02 Feb 2016

Price : $50

At a glance

  • Originator Genentech
  • Class
  • Mechanism of Action Neuron modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Amyotrophic lateral sclerosis

Most Recent Events

  • 01 Jan 2016 Phase-I clinical trials in Amyotrophic lateral sclerosis in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top